Mona-Elisabeth Revheim

  • Group leader, Assoc. Prof.; MD, PhD
  • +47 23070840
UiO email: m.e.rootwelt-revheim@medisin.uio.no
 

Publications 2022

Alavi A, Saboury B, Nardo L, Zhang V, Wang M, Li H, Raynor WY, Werner TJ, Høilund-Carlsen PF, Revheim ME (2022)
Potential and Most Relevant Applications of Total Body PET/CT Imaging
Clin Nucl Med, 47 (1), 43-55
DOI 10.1097/RLU.0000000000003962, PubMed 34874348

Alavi A, Werner TJ, Høilund-Carlsen PF, Revheim ME (2022)
Can Target-to-Background Ratio Measurement Lead to Detection and Accurate Quantification of Atherosclerosis With FDG PET? Likely Not
Clin Nucl Med, 47 (6), 532-536
DOI 10.1097/RLU.0000000000004131, PubMed 35384906

Borja AJ, Saini J, Raynor WY, Ayubcha C, Werner TJ, Alavi A, Revheim ME, Nagaraj C (2022)
Role of Molecular Imaging with PET/MR Imaging in the Diagnosis and Management of Brain Tumors
PET Clin, 17 (3), 431-451
DOI 10.1016/j.cpet.2022.03.002, PubMed 35662494

Helgebostad R, Revheim ME, Johnsrud K, Amlie K, Alavi A, Connelly JP (2022)
Clinical Applications of Somatostatin Receptor (Agonist) PET Tracers beyond Neuroendocrine Tumors
Diagnostics (Basel), 12 (2)
DOI 10.3390/diagnostics12020528, PubMed 35204618

Høilund-Carlsen PF, Revheim ME, Alavi A (2022)
Alzheimer's Disease at a Crossroad: Time to Part from Amyloid to More Promising Aspects- Atherosclerosis for a Start
J Alzheimers Dis (in press)
DOI 10.3233/JAD-220190, PubMed 35599491

Høilund-Carlsen PF, Werner TJ, Alavi A, Revheim ME (2022)
Aducanumab-Related Amyloid-Related Imaging Abnormalities: Paean or Lament?
Clin Nucl Med, 47 (7), 625-626
DOI 10.1097/RLU.0000000000004250, PubMed 35452007

Langen Stokmo H, Aly M, Bowitz Lothe IM, Borja AJ, Mehdizadeh Seraj S, Ghorpade R, Miao X, Hjortland GO, Malinen E, Sorbye H, Werner TJ, Alavi A, Revheim ME (2022)
Volumetric parameters from [18 F]FDG PET/CT predicts survival in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms
J Neuroendocrinol, e13170 (in press)
DOI 10.1111/jne.13170, PubMed 35729738

Løndalen A, Blakkisrud J, Revheim ME, Dahle J, Kolstad A, Stokke C (2022)
FDG PET/CT and Dosimetric Studies of 177Lu-Lilotomab Satetraxetan in a First-in-Human Trial for Relapsed Indolent non-Hodgkin Lymphoma-Are We Hitting the Target?
Mol Imaging Biol (in press)
DOI 10.1007/s11307-022-01731-3, PubMed 35486292

Müller EG, Edwin TH, Strand BH, Stokke C, Revheim ME, Knapskog AB (2022)
Is Amyloid Burden Measured by 18F-Flutemetamol PET Associated with Progression in Clinical Alzheimer's Disease?
J Alzheimers Dis, 85 (1), 197-205
DOI 10.3233/JAD-215046, PubMed 34776444

Müller EG, Stokke C, Stokmo HL, Edwin TH, Knapskog AB, Revheim ME (2022)
Evaluation of semi-quantitative measures of 18F-flutemetamol PET for the clinical diagnosis of Alzheimer's disease
Quant Imaging Med Surg, 12 (1), 493-509
DOI 10.21037/qims-21-188, PubMed 34993096

Park PSU, Raynor WY, Khurana N, Sun Y, Werner TJ, Høilund-Carlsen PF, Alavi A, Revheim ME (2022)
Application of 18F-NaF-PET/CT in assessing age-related changes in the cervical spine
Quant Imaging Med Surg, 12 (6), 3314-3324
DOI 10.21037/qims-21-1174, PubMed 35655822

Stenberg VY, Tornes AJK, Nilsen HR, Revheim ME, Bruland ØS, Larsen RH, Juzeniene A (2022)
Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand 212Pb-NG001
Cancers (Basel), 14 (11)
DOI 10.3390/cancers14112784, PubMed 35681766

Stokke C, Nørgaard JN, Feiring Phillips H, Sherwani A, Nuruddin S, Connelly J, Schjesvold F, Revheim ME (2022)
Comparison of [18F]fluciclovine and [18F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients
Mol Imaging Biol (in press)
DOI 10.1007/s11307-022-01734-0, PubMed 35501622

Zirakchian Zadeh M, Asadollahi S, Kaghazchi F, Raynor WY, Mehdizadeh Seraj S, Werner TJ, Seierstad T, Korostoff J, Swisher-McClure S, Alavi A, Revheim ME (2022)
Prognostic significance of conventional and volumetric PET parameters with and without partial volume correction in the assessment of head and neck squamous cell carcinoma
Nucl Med Commun, 43 (7), 800-806
DOI 10.1097/MNM.0000000000001573, PubMed 35552334

Publications 2021

Alavi A, Werner TJ, Raynor W, Høilund-Carlsen PF, Revheim ME (2021)
Critical review of PET imaging for detection and characterization of the atherosclerotic plaques with emphasis on limitations of FDG-PET compared to NaF-PET in this setting
Am J Nucl Med Mol Imaging, 11 (5), 337-351
PubMed 34754605

Arani LS, Zirakchian Zadeh M, Saboury B, Revheim ME, Øestergaard B, Borja AJ, Samadi Samarin D, Mehdizadeh Seraj S, Kalbush E, Ayubcha C, Morris MA, Werner TJ, Abildgaard N, Høilund-Carlsen PF, Alavi A (2021)
Assessment of atherosclerosis in multiple myeloma and smoldering myeloma patients using 18F- sodium fluoride PET/CT
J Nucl Cardiol, 28 (6), 3044-3054
DOI 10.1007/s12350-020-02446-0, PubMed 33389640

Ayubcha C, Moghbel M, Borja AJ, Newberg A, Werner TJ, Alavi A, Revheim ME (2021)
Tau Imaging in Head Injury
PET Clin, 16 (2), 249-260
DOI 10.1016/j.cpet.2020.12.009, PubMed 33648666

Ayubcha C, Raynor WY, Borja AJ, Seraj SM, Rojulpote C, Werner TJ, Revheim ME, Rajapakse CS, Alavi A (2021)
Magnetic resonance imaging-based partial volume-corrected 18F-sodium fluoride positron emission tomography in the femoral neck
Nucl Med Commun, 42 (4), 416-420
DOI 10.1097/MNM.0000000000001344, PubMed 33306627

Borja AJ, Hancin EC, Raynor WY, Ayubcha C, Detchou DK, Werner TJ, Revheim ME, Alavi A (2021)
A Critical Review of PET Tracers Used for Brain Tumor Imaging
PET Clin, 16 (2), 219-231
DOI 10.1016/j.cpet.2020.12.004, PubMed 33589386

Borja AJ, Hancin EC, Zhang V, Koa B, Bhattaru A, Rojulpote C, Detchou DK, Aly M, Kaghazchi F, Gerke O, Patil S, Gonuguntla K, Werner TJ, Revheim ME, Høilund-Carlsen PF, Alavi A (2021)
Global brain glucose uptake on 18F-FDG-PET/CT is influenced by chronic cardiovascular risk
Nucl Med Commun, 42 (4), 444-450
DOI 10.1097/MNM.0000000000001349, PubMed 33323870

Fraz MSA, Moe N, Revheim ME, Stavrinou ML, Durheim MT, Nordøy I, Macpherson ME, Aukrust P, Jørgensen SF, Aaløkken TM, Fevang B (2021)
Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency-Features of CT and 18F-FDG Positron Emission Tomography/CT in Clinically Progressive Disease
Front Immunol, 11, 617985
DOI 10.3389/fimmu.2020.617985, PubMed 33584710

Hancin EC, Raynor WY, Borja AJ, Werner TJ, Revheim ME, Alavi A (2021)
Non-18F-FDG/18F-NaF Radiotracers Proposed for the Diagnosis and Management of Diseases of the Heart and Vasculature
PET Clin, 16 (2), 273-284
DOI 10.1016/j.cpet.2020.12.005, PubMed 33589388

Hernes E, Revheim ME, Hole KH, Tulipan AJ, Strømme H, Lilleby W, Seierstad T (2021)
Prostate-Specific Membrane Antigen PET for Assessment of Primary and Recurrent Prostate Cancer with Histopathology as Reference Standard: A Systematic Review and Meta-Analysis
PET Clin, 16 (2), 147-165
DOI 10.1016/j.cpet.2020.12.001, PubMed 33648661

Hole KH, Tulipan AJ, Reijnen JS, Hernes E, Vlatkovic L, Lie AK, Revheim ME, Seierstad T (2021)
Localization of primary prostate cancer: FACBC PET/CT compared with multiparametric MRI using histopathology as reference standard
Am J Nucl Med Mol Imaging, 11 (5), 387-394
PubMed 34754609

Jahangiri P, Dreyfuss AD, Duan F, Snyder BS, Borja AJ, Pournazari K, Kothekar E, Arani L, Al-Zaghal A, Seraj SM, Hancin EC, Pinheiro B, Werner TJ, Swisher-McClure S, Feigenberg SJ, Torigian DA, Revheim ME, Simone CB, Alavi A (2021)
Implementation of FDG-PET/CT imaging methodology for quantification of inflammatory response in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial
Am J Nucl Med Mol Imaging, 11 (5), 415-427
PubMed 34754612

Kaghazchi F, Borja AJ, Hancin EC, Bhattaru A, Detchou DKE, Seraj SM, Rojulpote C, Hess S, Nardo L, Gabriel PE, Damrauer SM, Werner TJ, Alavi A, Revheim ME (2021)
Venous thromboembolism detected by FDG-PET/CT in cancer patients: a common, yet life-threatening observation
Am J Nucl Med Mol Imaging, 11 (2), 99-106
PubMed 34079639

Koa B, Borja AJ, Aly M, Padmanabhan S, Tran J, Zhang V, Rojulpote C, Pierson SK, Tamakloe MA, Khor JS, Werner TJ, Fajgenbaum DC, Alavi A, Revheim ME (2021)
Emerging role of 18F-FDG PET/CT in Castleman disease: a review
Insights Imaging, 12 (1), 35
DOI 10.1186/s13244-021-00963-1, PubMed 33709329

Koa B, Borja AJ, Yellanki D, Rojulpote C, Tran J, Zhang V, Werner TJ, Alavi A, Revheim ME (2021)
18F-FDG-PET/CT in the assessment of atherosclerosis in lung cancer
Am J Nucl Med Mol Imaging, 11 (1), 1-9
PubMed 33688450

Koa B, Borja AJ, Yellanki D, Rojulpote C, Tran J, Zhang V, Werner TJ, Alavi A, Revheim ME (2021)
F-18-FDG-PET/CT in the assessment of atherosclerosis in lung cancer
Am. J. Nucl. Med. Molec. Imaging, 11 (1), 1-+

Lynch C, Reguilon I, Langer DL, Lane D, De P, Wong WL, Mckiddie F, Ross A, Shack L, Win T, Marshall C, Revheim ME, Danckert B, Butler J, Dizdarevic S, Louzado C, Mcgivern C, Hazlett A, Chew C, O'connell M, Harrison S (2021)
A comparative analysis: international variation in PET-CT service provision in oncology-an International Cancer Benchmarking Partnership study
Int J Qual Health Care, 33 (1)
DOI 10.1093/intqhc/mzaa166, PubMed 33306102

Raynor WY, Borja AJ, Hancin EC, Werner TJ, Alavi A, Revheim ME (2021)
Novel Musculoskeletal and Orthopedic Applications of 18F-Sodium Fluoride PET
PET Clin, 16 (2), 295-311
DOI 10.1016/j.cpet.2020.12.006, PubMed 33589389

Raynor WY, Park PSU, Borja AJ, Sun Y, Werner TJ, Ng SJ, Lau HC, Høilund-Carlsen PF, Alavi A, Revheim ME (2021)
PET-Based Imaging with 18F-FDG and 18F-NaF to Assess Inflammation and Microcalcification in Atherosclerosis and Other Vascular and Thrombotic Disorders
Diagnostics (Basel), 11 (12)
DOI 10.3390/diagnostics11122234, PubMed 34943473

Revheim ME, Alavi A (2021)
PET-based Novel Imaging Techniques with Recently Introduced Radiotracers. Preface
PET Clin, 16 (2), xv-xvi
DOI 10.1016/j.cpet.2021.01.001, PubMed 33648667

Revheim ME, Hole KH, Mo T, Bruland ØS, Reitan E, Julsrud L, Seierstad T (2021)
Multimodal functional imaging for early response assessment in patients with gastrointestinal stromal tumor treated with tyrosine kinase inhibitors
Acta Radiol, 02841851211027389
DOI 10.1177/02841851211027389, PubMed 34171968

Rigney G, Ayubcha C, Werner TJ, Alavi A, Revheim ME (2021)
The utility of PET imaging in the diagnosis and management of psychosis: a brief review
Clin. Transl. Imaging
DOI 10.1007/s40336-021-00466-5

Seierstad T, Hole KH, Tulipan AJ, Strømme H, Lilleby W, Revheim ME, Hernes E (2021)
18F-Fluciclovine PET for Assessment of Prostate Cancer with Histopathology as Reference Standard: A Systematic Review
PET Clin, 16 (2), 167-176
DOI 10.1016/j.cpet.2020.12.012, PubMed 33648662

Tulipan AJ, Salberg UB, Hole KH, Vlatkovic L, Aarnes EK, Revheim ME, Lyng H, Seierstad T (2021)
Amino acid transporter expression and 18F-FACBC uptake at PET in primary prostate cancer
Am J Nucl Med Mol Imaging, 11 (4), 250-259
PubMed 34513278

Publications 2020

Aksnes M, Müller EG, Tiiman A, Edwin TH, Terenius L, Revheim ME, Vukojević V, Bogdanović N, Knapskog AB (2020)
Amyloidogenic Nanoplaques in Cerebrospinal Fluid: Relationship to Amyloid Brain Uptake and Clinical Alzheimer's Disease in a Memory Clinic Cohort
J Alzheimers Dis, 77 (2), 831-842
DOI 10.3233/JAD-200237, PubMed 32741818

Ayubcha C, Revheim ME, Newberg A, Moghbel M, Rojulpote C, Werner TJ, Alavi A (2020)
A critical review of radiotracers in the positron emission tomography imaging of traumatic brain injury: FDG, tau, and amyloid imaging in mild traumatic brain injury and chronic traumatic encephalopathy
Eur J Nucl Med Mol Imaging, 48 (2), 623-641
DOI 10.1007/s00259-020-04926-4, PubMed 32696090

Borja AJ, Hancin EC, Dreyfuss AD, Zhang V, Mathew T, Rojulpote C, Werner TJ, Patil S, Gonuguntla K, Lin A, Feigenberg SJ, Swisher-McClure S, Alavi A, Revheim ME (2020)
18F-FDG-PET/CT in the quantification of photon radiation therapy-induced vasculitis
Am J Nucl Med Mol Imaging, 10 (1), 66-73
PubMed 32211220

Borja AJ, Hancin EC, Dreyfuss AD, Zhang V, Mathew T, Rojulpote C, Werner TJ, Patil S, Gonuguntla K, Lin A, Feigenberg SJ, Swisher-McClure S, Alavi A, Revheim ME (2020)
F-18-FDG-PET/CT in the quantification of photon radiation therapy-induced vasculitis
Am. J. Nucl. Med. Molec. Imaging, 10 (1), 66-73

Borja AJ, Hancin EC, Zhang V, Revheim ME, Alavi A (2020)
Potential of PET/CT in assessing dementias with emphasis on cerebrovascular disorders
Eur J Nucl Med Mol Imaging, 47 (11), 2493-2498
DOI 10.1007/s00259-020-04697-y, PubMed 31982989

Johnsrud K, Seierstad T, Russell D, Revheim ME (2020)
Inter-reader agreement of 18F-FDG PET/CT for the quantification of carotid artery plaque inflammation
JRSM Cardiovasc Dis, 9, 2048004020980941
DOI 10.1177/2048004020980941, PubMed 33403110

Kothekar E, Revheim ME, Borja AJ, Hancin EC, Detchou DK, Werner TJ, Shin DB, Gelfand JM, Alavi A (2020)
Utility of FDG-PET/CT in clinical psoriasis grading: the PET-PASI scoring system
Am J Nucl Med Mol Imaging, 10 (5), 265-271
PubMed 33224623

Kothekar E, Yellanki D, Borja AJ, Al-Zaghal A, Werner TJ, Revheim ME, Gerke O, Saboury B, Gholamrezanezad A, Høilund-Carlsen PF, Alavi A (2020)
18F-FDG-PET/CT in measuring volume and global metabolic activity of thigh muscles: a novel CT-based tissue segmentation methodology
Nucl Med Commun, 41 (2), 162-168
DOI 10.1097/MNM.0000000000001127, PubMed 31860525

Løndalen A, Blakkisrud J, Revheim ME, Madsbu UE, Dahle J, Kolstad A, Stokke C (2020)
FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of 177Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma
Eur J Nucl Med Mol Imaging, 48 (6), 1902-1914
DOI 10.1007/s00259-020-05098-x, PubMed 33196921

Mayer M, Borja AJ, Hancin EC, Auslander T, Revheim ME, Moghbel MC, Werner TJ, Alavi A, Rajapakse CS (2020)
Imaging Atherosclerosis by PET, With Emphasis on the Role of FDG and NaF as Potential Biomarkers for This Disorder
Front Physiol, 11, 511391
DOI 10.3389/fphys.2020.511391, PubMed 33192540

Mouminah A, Borja AJ, Hancin EC, Chang YC, Werner TJ, Swisher-McClure S, Korostoff J, Alavi A, Revheim ME (2020)
18F-FDG-PET/CT in radiation therapy-induced parotid gland inflammation
Eur J Hybrid Imaging, 4 (1), 22
DOI 10.1186/s41824-020-00091-x, PubMed 34191165

Paydary K, Revheim ME, Emamzadehfard S, Gholami S, Pourhassan S, Werner TJ, Høilund-Carlsen PF, Alavi A (2020)
Quantitative thoracic aorta calcification assessment by 18F-NaF PET/CT and its correlation with atherosclerotic cardiovascular disorders and increasing age
Eur Radiol, 31 (2), 785-794
DOI 10.1007/s00330-020-07133-9, PubMed 32870396

Pourhassan Shamchi S, Zirakchian Zadeh M, Østergaard B, Kim J, Raynor WY, Khosravi M, Taghvaei R, Nielsen AL, Gerke O, Werner TJ, Holdgaard P, Abildgaard N, Revheim ME, Høilund-Carlsen PF, Alavi A (2020)
Brain glucose metabolism in patients with newly diagnosed multiple myeloma significantly decreases after high-dose chemotherapy followed by autologous stem cell transplantation
Nucl Med Commun, 41 (3), 288-293
DOI 10.1097/MNM.0000000000001144, PubMed 31895757

Rogne AG, Müller EG, Udnaes E, Sigurdardottir S, Raudeberg R, Connelly JP, Revheim ME, Hassel B, Dahlberg D (2020)
β-Amyloid may accumulate in the human brain after focal bacterial infection: An 18 F-flutemetamol positron emission tomography study
Eur J Neurol, 28 (3), 877-883
DOI 10.1111/ene.14622, PubMed 33131195

Seraj SM, Raynor WY, Revheim ME, Al-Zaghal A, Zadeh MZ, Arani LS, Rojulpote C, Werner TJ, Gerke O, Høilund-Carlsen PF, Baker JF, Alavi A, Hunt SJ (2020)
Assessing the feasibility of NaF-PET/CT versus FDG-PET/CT to detect abdominal aortic calcification or inflammation in rheumatoid arthritis patients
Ann Nucl Med, 34 (6), 424-431
DOI 10.1007/s12149-020-01463-w, PubMed 32277422

Zadeh MZ, Raynor WY, Ostergaard B, Hess S, Yellanki DP, Ayubcha C, Seraj SM, Acosta-Montenegro O, Borja AJ, Gerke O, Werner TJ, Zhuang HM, Revheim ME, Abildgaard N, Hoilund-Carlsen PF, Alavi A (2020)
Correlation of whole-bone marrow dual-time-point F-18-FDG, as measured by a CT-based method of PET/CT quantification, with response to treatment in newly diagnosed multiple myeloma patients
Am. J. Nucl. Med. Molec. Imaging, 10 (5), 257-264

Zadeh MZ, Seraj SM, Østergaard B, Mimms S, Raynor WY, Aly M, Borja AJ, Arani LS, Gerke O, Werner TJ, Zhuang H, Revheim ME, Abildgaard N, Høilund-Carlsen PF, Alavi A (2020)
Prognostic significance of 18F-sodium fluoride in newly diagnosed multiple myeloma patients
Am J Nucl Med Mol Imaging, 10 (4), 151-160
PubMed 32929393

Zhang V, Borja AJ, Rojulpote C, Padmanabhan S, Patil S, Gonuguntla K, Revheim ME, Werner TJ, Høilund-Carlsen PF, Alavi A (2020)
Global quantification of pulmonary artery atherosclerosis using 18F-sodium fluoride PET/CT in at-risk subjects
Am J Nucl Med Mol Imaging, 10 (2), 119-126
PubMed 32419980

Zhang V, Koa B, Borja AJ, Padmanhabhan S, Bhattaru A, Raynor WY, Rojulpote C, Seraj SM, Werner TJ, Rajapakse C, Alavi A, Revheim ME (2020)
Diagnosis and Monitoring of Osteoporosis with Total-Body 18F-Sodium Fluoride-PET/CT
PET Clin, 15 (4), 487-496
DOI 10.1016/j.cpet.2020.06.011, PubMed 32768370

Zirakchian Zadeh M, Raynor WY, Østergaard B, Hess S, Yellanki DP, Ayubcha C, Mehdizadeh Seraj S, Acosta-Montenegro O, Borja AJ, Gerke O, Werner TJ, Zhuang H, Revheim ME, Abildgaard N, Høilund-Carlsen PF, Alavi A (2020)
Correlation of whole-bone marrow dual-time-point 18F-FDG, as measured by a CT-based method of PET/CT quantification, with response to treatment in newly diagnosed multiple myeloma patients
Am J Nucl Med Mol Imaging, 10 (5), 257-264
PubMed 33224622

Zirakchian Zadeh M, Østergaard B, Raynor WY, Revheim ME, Seraj SM, Acosta-Montenegro O, Ayubcha C, Yellanki DP, Al-Zaghal A, Nielsen AL, Constantinescu CM, Gerke O, Werner TJ, Zhuang H, Abildgaard N, Høilund-Carlsen PF, Alavi A (2020)
Comparison of 18F-sodium fluoride uptake in the whole bone, pelvis, and femoral neck of multiple myeloma patients before and after high-dose therapy and conventional-dose chemotherapy
Eur J Nucl Med Mol Imaging, 47 (12), 2846-2855
DOI 10.1007/s00259-020-04768-0, PubMed 32246208

Publications 2019

Kothekar E, Borja AJ, Gerke O, Werner TJ, Alavi A, Revheim ME (2019)
Assessing respitatory muscle activity with 18F-FDG-PET/CT in patients with COPD
Am J Nucl Med Mol Imaging, 9 (6), 309-315
PubMed 31976160

Mirzaei S, Revheim ME, Raynor W, Zehetner W, Knoll P, Zandieh S, Alavi A (2019)
64Cu-DOTATOC PET-CT in Patients with Neuroendocrine Tumors
Oncol Ther, 8 (1), 125-131
DOI 10.1007/s40487-019-00104-1, PubMed 32700066

Müller EG, Edwin TH, Stokke C, Navelsaker SS, Babovic A, Bogdanovic N, Knapskog AB, Revheim ME (2019)
Amyloid-β PET-Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic
PLoS One, 14 (8), e0221365
DOI 10.1371/journal.pone.0221365, PubMed 31430334

Publications 2018

de Lange C, Solberg R, Holtedahl JE, Tulipan A, Barlinn J, Trigg W, Wickstrøm T, Saugstad OD, Malinen E, Revheim ME (2018)
Dynamic TSPO-PET for assessing early effects of cerebral hypoxia and resuscitation in new born pigs
Nucl Med Biol, 66, 49-57
DOI 10.1016/j.nucmedbio.2018.08.004, PubMed 30257223

Grut H, Revheim ME, Line PD, Dueland S (2018)
Importance of 18F-FDG PET/CT to select patients with nonresectable colorectal liver metastases for liver transplantation
Nucl Med Commun, 39 (7), 621-627
DOI 10.1097/MNM.0000000000000843, PubMed 29683930

Halsne T, Müller EG, Spiten AE, Sherwani AG, Gyland Mikalsen LT, Revheim ME, Stokke C (2018)
The Effect of New Formulas for Lean Body Mass on Lean-Body-Mass-Normalized SUV in Oncologic 18F-FDG PET/CT
J Nucl Med Technol, 46 (3), 253-259
DOI 10.2967/jnmt.117.204586, PubMed 29599401

Hompland I, Hølmebakk T, Boye K, Stoldt S, Bjerkehagen B, Berner JM, Wiedswang AM, Revheim ME, Poulsen JP, Hall KS, Bruland ØS (2018)
Multimodal kreftbehandling av gastrointestinal stromal tumor
Tidsskr Nor Laegeforen, 138 (15)
DOI 10.4045/tidsskr.18.0200, PubMed 30277049

Tulipan AJ, Hole KH, Vlatkovic L, Revheim ME, Reijnen JS, Willoch F, Seierstad T, Lilleby W (2018)
Localization of radio-recurrence within the prostate: anti-3-18F-FACBC PET/CT compared with multiparametric MRI using histopathology as reference standard
Acta Radiol, 60 (8), 1028-1038
DOI 10.1177/0284185118810977, PubMed 30379559

Tulipan AJ, Vlatkovic L, Malinen E, Brennhovd B, Hole KH, Lie AK, Ragnum HB, Revheim ME, Seierstad T (2018)
Comparison of time curves from dynamic 18F-fluciclovine positron emission tomography and dynamic contrast-enhanced magnetic resonance imaging for primary prostate carcinomas
Phys Imaging Radiat Oncol, 7, 51-57
DOI 10.1016/j.phro.2018.09.003, PubMed 33458405

Publications 2017

Ausland L, Revheim ME, Skretting A, Stokke C (2017)
Respiratory motion during 90Yttrium PET contributes to underestimation of tumor dose and overestimation of normal liver tissue dose
Acta Radiol, 59 (2), 132-139
DOI 10.1177/0284185117710052, PubMed 28509566

Grut H, Dueland S, Line PD, Revheim ME (2017)
The prognostic value of 18F-FDG PET/CT prior to liver transplantation for nonresectable colorectal liver metastases
Eur J Nucl Med Mol Imaging, 45 (2), 218-225
DOI 10.1007/s00259-017-3843-9, PubMed 29026950

Grut H, Solberg S, Seierstad T, Revheim ME, Egge TS, Larsen SG, Line PD, Dueland S (2017)
Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases
Br J Surg, 105 (3), 295-301
DOI 10.1002/bjs.10651, PubMed 29168565

Johnsrud K, Skagen K, Seierstad T, Skjelland M, Russell D, Revheim ME (2017)
18F-FDG PET/CT for the quantification of inflammation in large carotid artery plaques
J Nucl Cardiol, 26 (3), 883-893
DOI 10.1007/s12350-017-1121-7, PubMed 29209949

Publications 2015

Lilleby W, Vlatkovic L, Meza-Zepeda LA, Revheim ME, Hovig E (2015)
Translocational renal cell carcinoma (t(6;11)(p21;q12) with transcription factor EB (TFEB) amplification and an integrated precision approach: a case report
J Med Case Rep, 9, 281
DOI 10.1186/s13256-015-0749-7, PubMed 26654961

Skagen K, Johnsrud K, Evensen K, Scott H, Krohg-Sørensen K, Reier-Nilsen F, Revheim ME, Fjeld JG, Skjelland M, Russell D (2015)
Carotid plaque inflammation assessed with (18)F-FDG PET/CT is higher in symptomatic compared with asymptomatic patients
Int J Stroke, 10 (5), 730-6
DOI 10.1111/ijs.12430, PubMed 25588553

Publications 2014

Revheim ME, Haugvik SP, Johnsrud K, Mathisen Ø, Fjeld JG, Skretting A (2014)
Respiratory gated and prolonged acquisition 18F-FDG PET improve preoperative assessment of colorectal liver metastases
Acta Radiol, 56 (4), 397-403
DOI 10.1177/0284185114529563, PubMed 24682406

Røe OD, Oppegaard PA, Revheim ME, Svindland A (2014)
Adrenocortical carcinoma mimicking lung cancer and responding to vinorelbine/carboplatin and pemetrexed/carboplatin
BMJ Case Rep, 2014
DOI 10.1136/bcr-2014-206225, PubMed 25391823

Publications 2013

Fløisand Y, Beiske K, Tjønnfjord GE, Heldal D, Bjerkehagen B, Revheim ME, Heim S, Bruland OS, Hall KS, Tierens A, Delabie J (2013)
Malignant phyllodes tumor and acute megakaryoblastic leukemia sharing a common clonal origin
Case Rep Hematol, 2013, 934781
DOI 10.1155/2013/934781, PubMed 24455338

Kristian A, Nilsen LB, Røe K, Revheim ME, Engebråten O, Mælandsmo GM, Holm R, Malinen E, Seierstad T (2013)
Dynamic (18) F-FDG PET for Assessment of Tumor Physiology in Two Breast Carcinoma Xenografts
Nucl Med Mol Imaging, 47 (3), 173-80
DOI 10.1007/s13139-013-0211-y, PubMed 24900104

Kristian A, Revheim ME, Qu H, Mælandsmo GM, Engebråten O, Seierstad T, Malinen E (2013)
Dynamic (18)F-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts
Acta Oncol, 52 (7), 1566-72
DOI 10.3109/0284186X.2013.813634, PubMed 23984812

Revheim ME, Hole KH, Bruland OS, Reitan E, Bjerkehagen B, Julsrud L, Seierstad T (2013)
Multimodal functional imaging for early response assessment in GIST patients treated with imatinib
Acta Oncol, 53 (1), 143-8
DOI 10.3109/0284186X.2013.798428, PubMed 23710697

Revheim ME, Kristian A, Malinen E, Bruland ØS, Berner JM, Holm R, Joensuu H, Seierstad T (2013)
Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H
Acta Oncol, 52 (4), 776-82
DOI 10.3109/0284186X.2013.770920, PubMed 23480638

Skretting A, Revheim ME, Knudtsen IS, Johnsrud K, Bogsrud TV (2013)
An implementation of time-efficient respiratory-gated PET acquisition by repeated breath-holds
Acta Radiol, 54 (6), 672-5
DOI 10.1177/0284185113478007, PubMed 23463858

Publications 2012

Bolstad N, Kazaryan AM, Revheim ME, Distante S, Johnsrud K, Warren DJ, Nustad K, Edwin B (2012)
A man with abdominal pain: enough evidence for surgery?
Clin Chem, 58 (8), 1187-90
DOI 10.1373/clinchem.2011.167015, PubMed 22843812

Rusten E, Rødal J, Revheim ME, Skretting A, Bruland OS, Malinen E (2012)
Quantitative dynamic ¹⁸FDG-PET and tracer kinetic analysis of soft tissue sarcomas
Acta Oncol, 52 (6), 1160-7
DOI 10.3109/0284186X.2012.728713, PubMed 23198721

Publications 2011

Revheim ME, Røe K, Bruland ØS, Bach-Gansmo T, Skretting A, Seierstad T (2011)
Monitoring the effect of targeted therapies in a gastrointestinal stromal tumor xenograft using a clinical PET/CT
Mol Imaging Biol, 13 (6), 1234-40
DOI 10.1007/s11307-010-0464-0, PubMed 21161686

Publications 2010

Revheim ME, Hole KH, Bruland OS, Haugland HK, Hall KS, Seierstad T (2010)
DW MRI for evaluation of treatment response to imatinib in a rectal gastrointestinal stromal tumour
Acta Oncol, 50 (1), 148-50
DOI 10.3109/0284186X.2010.516273, PubMed 21110775

Revheim ME, Winge-Main AK, Hagen G, Fjeld JG, Fosså SD, Lilleby W (2010)
Combined positron emission tomography/computed tomography in sunitinib therapy assessment of patients with metastatic renal cell carcinoma
Clin Oncol (R Coll Radiol), 23 (5), 339-43
DOI 10.1016/j.clon.2010.11.006, PubMed 21134733

Publications 2009

Revheim ME, Seierstad T, Berner JM, Bruland OS, Røe K, Ohnstad HO, Bjerkehagen B, Bach-Gansmo T (2009)
Establishment and characterization of a human gastrointestinal stromal tumour (GIST) xenograft in athymic nude mice
Anticancer Res, 29 (11), 4331-6
PubMed 20032375

Page visits: 11006